In study COSS-80 113 evaluable patients (pts) received neoadjuvant preoperative chemotherapy (prop CT) with highdose methotrexate (HD-MTX), doxorubicine (DOX) and either cisplatinum (DDP) or the triple drug combination bleomy-cine&cyclophosphamide&dactinomycine (BCD). Half of the pts received in addition fibroblast interferon following surgery in wk 12. The degree to which the histologic grade of tumor cell destruction (TCD) after prop CT correlates with freedom from metastatic disease was studied. By regression analysis according to the Cox' model, we found the following characteristics to be significant risk factors: poor response (TCD ~ 90%) to prop CT (p = .006), tumor size of > i/3 of involved bone (p = .013) and en bloc resection as opposed to more radical surgical procedures (p = .03).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.